|
Product Name |
CAS No. |
|
|
DMT-2'-OMe-Pseudouridine-CE-Phosphoramidite |
199737-09-2 |
|
|
DMT-2'-deoxy-N1-methyl-Pseudouridine-CE-Phosphoramidite |
N/A |
|
|
DMT-2'-O-TBDMS-N1-methyl-Pseudouridine-CE-Phosphoramidite |
875302-45-7 |
|
|
DMT-2'-O-TBDMS-Pseudouridine-CE-Phosphoramidite |
163496-23-9 |
|
Unmatched Versatility for Tailored RNA Design: Our portfolio spans multiple sugar modifications, allowing researchers to select the optimal pseudouridine variant for their specific needs. The 2'-OMe and 2'-deoxy versions are ideal for enhancing nuclease resistance in antisense and siRNA applications, while the 2'-O-TBDMS variants are specifically designed for standard RNA synthesis, enabling the incorporation of pseudouridine into longer mRNA constructs.
Enhanced Translational Efficiency and Immune Evasion: Pseudouridine and its N1-methylated derivative are renowned for their ability to dramatically reduce innate immune activation while boosting protein translation. By offering both methylated and non-methylated forms across different sugar backbones, Cosperpharma empowers you to precisely control the biological properties of your RNA therapeutics.
Rigorous Quality Control for Sensitive Applications: Every lot of our Pseudouridine Phosphoramidites undergoes stringent HPLC purity verification and structural confirmation. This ensures the highest coupling efficiency and product fidelity, which is critical for mRNA vaccine and therapeutic manufacturing where even trace impurities can impact clinical outcomes.
Scalable Supply to Match Your Pipeline: From milligram-scale research samples to kilogram-scale commercial production, Cosperpharma provides flexible packaging and delivery options to support your project at every stage of development.
Cosperpharma’s Pseudouridine Phosphoramidites are essential for a broad spectrum of advanced RNA applications:
mRNA Vaccines and Therapeutics: Enabling the production of highly translatable, low-immunogenicity mRNA constructs for vaccines and protein replacement therapies.
Antisense Oligonucleotides (ASOs) and siRNA: Enhancing metabolic stability and potency through the incorporation of 2'-OMe or 2'-deoxy pseudouridine variants.
Gene Editing: Improving the performance and stability of CRISPR guide RNAs and repair templates.
Basic RNA Biology Research: Facilitating studies on RNA structure, stability, and innate immune recognition.
We are dedicated to supporting your RNA research with the highest quality modified nucleosides. If you are interested in evaluating our expanded Pseudouridine portfolio or would like to discuss your specific synthesis requirements, we encourage you to reach out. Contact Cosperpharma today to request a sample, obtain a detailed specification sheet, or receive a customized quotation for your next project.
No. 2 Yangguang 3rd Road, Duodao Chemical Cycle Industrial Park, Jingmen City, Hubei Province, China
Copyright © 2026 Cosper Pharma Tech Co., Ltd. All Rights Reserved.